Drugs / LY3478006
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04230122 | Feb → Jun 2020 | — | Eli Lilly and Company | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LY3478006 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04230122 ↗ |
| Route | Intravenous | “administered IV” NCT04230122 ↗ |